BR9711002B1 - análogo do hormÈnio da paratireóide para o tratamento de osteoporose. - Google Patents

análogo do hormÈnio da paratireóide para o tratamento de osteoporose. Download PDF

Info

Publication number
BR9711002B1
BR9711002B1 BRPI9711002-7A BR9711002A BR9711002B1 BR 9711002 B1 BR9711002 B1 BR 9711002B1 BR 9711002 A BR9711002 A BR 9711002A BR 9711002 B1 BR9711002 B1 BR 9711002B1
Authority
BR
Brazil
Prior art keywords
hpth
seq
leu
cycle
analog
Prior art date
Application number
BRPI9711002-7A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9711002A (pt
Inventor
Jean-Rene Barbier
Paul Morley
Witold Neugebauer
Virginia Ross
James Whitfield
Gordon E Willick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,647 external-priority patent/US5955425A/en
Application filed filed Critical
Publication of BR9711002A publication Critical patent/BR9711002A/pt
Publication of BR9711002B1 publication Critical patent/BR9711002B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Radiation (AREA)
BRPI9711002-7A 1996-08-02 1997-08-01 análogo do hormÈnio da paratireóide para o tratamento de osteoporose. BR9711002B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/691,647 US5955425A (en) 1996-08-02 1996-08-02 Parathyroid hormone analogues for the treatment of osteoporosis
US08/691.647 1996-08-02
US4056097P 1997-03-14 1997-03-14
US60/040.560 1997-03-14
PCT/CA1997/000547 WO1998005683A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (2)

Publication Number Publication Date
BR9711002A BR9711002A (pt) 2002-01-15
BR9711002B1 true BR9711002B1 (pt) 2011-09-06

Family

ID=26717175

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9711002-7A BR9711002B1 (pt) 1996-08-02 1997-08-01 análogo do hormÈnio da paratireóide para o tratamento de osteoporose.

Country Status (24)

Country Link
EP (1) EP0915911B1 (enExample)
JP (3) JP4122061B2 (enExample)
KR (1) KR100500859B1 (enExample)
CN (1) CN1176947C (enExample)
AT (1) ATE253078T1 (enExample)
AU (1) AU723728B2 (enExample)
BG (1) BG103128A (enExample)
BR (1) BR9711002B1 (enExample)
CA (1) CA2261564C (enExample)
CZ (1) CZ34799A3 (enExample)
DE (1) DE69725850T2 (enExample)
DK (1) DK0915911T3 (enExample)
EE (1) EE9900039A (enExample)
ES (1) ES2207740T3 (enExample)
FI (1) FI990126A7 (enExample)
GE (1) GEP20033095B (enExample)
IS (1) IS4962A (enExample)
LV (1) LV12293B (enExample)
NZ (1) NZ333809A (enExample)
PT (1) PT915911E (enExample)
RU (1) RU2203286C2 (enExample)
SI (1) SI9720057A (enExample)
SK (1) SK287397B6 (enExample)
WO (1) WO1998005683A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1261281A (zh) * 1997-05-14 2000-07-26 罗纳·布朗克罗尔药制品有限公司 肽甲状旁腺激素类似物
JP4486256B2 (ja) 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
AU1633200A (en) 1998-11-25 2000-06-13 General Hospital Corporation, The Human parathyroid hormone modifications, preparation and use
WO2000040698A1 (en) 1998-12-31 2000-07-13 The General Hospital Corporation Pth receptor and screening assay utilizing the same
JP2003505514A (ja) * 1999-07-28 2003-02-12 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 破骨細胞生成を阻害する方法
US6316410B1 (en) * 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
JP4959917B2 (ja) * 2001-08-17 2012-06-27 ノバルティス アーゲー 副甲状腺ホルモンフラグメント用経口送達剤としての５−ｃｎａｃ
MXPA04006728A (es) 2002-01-10 2005-08-19 Osteotrophin Llc Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos.
EP1567178A4 (en) * 2002-11-01 2009-07-15 Amgen Inc MODULATORS OF RECEPTORS FOR NEUTRAL THERAPY HORMONE AND SIDE-HORSE HORMONE-RELATED PROTEINS
CN100508957C (zh) * 2003-01-21 2009-07-08 尤尼金实验室股份有限公司 肽经口输递的改进
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2007130113A2 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
EP2056862A2 (en) * 2006-07-31 2009-05-13 Zelos Therapeutics, Inc. Parathyroid hormone analogues and uses thereof
KR101108354B1 (ko) 2006-10-13 2012-01-25 일라이 릴리 앤드 캄파니 Ｐｔｈ 수용체 조절제로서의 페길화된 ｐｔｈ 및 그의 용도
CA2694667C (en) 2007-08-01 2018-10-30 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
RU2604809C2 (ru) * 2010-05-13 2016-12-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги паратиреоидного гормона и их применение
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
WO2019018238A1 (en) 2017-07-15 2019-01-24 The Regents Of The University Of California CATHEPSIN K OSTEOADSORBENT FLUOROGEN SUBSTRATE FOR THE IMAGING OF OSTEOCLAST ACTIVITY AND MIGRATION
WO2020064190A1 (en) 2018-09-26 2020-04-02 Borealis Ag Propylene copolymer composition with excellent optical and mechanical properties
CN113549144A (zh) * 2021-06-30 2021-10-26 华南理工大学 一种特立帕肽hPTH(1-34)的生产和纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis

Also Published As

Publication number Publication date
CN1231676A (zh) 1999-10-13
JP4122061B2 (ja) 2008-07-23
CA2261564C (en) 2007-10-30
ATE253078T1 (de) 2003-11-15
SK13299A3 (en) 1999-10-08
KR20000029783A (ko) 2000-05-25
JP2007254480A (ja) 2007-10-04
SK287397B6 (sk) 2010-08-09
AU723728B2 (en) 2000-09-07
DE69725850T2 (de) 2004-08-19
SI9720057A (sl) 1999-12-31
FI990126A0 (fi) 1999-01-22
DE69725850D1 (de) 2003-12-04
AU3690597A (en) 1998-02-25
BR9711002A (pt) 2002-01-15
CZ34799A3 (cs) 1999-07-14
GEP20033095B (en) 2003-10-27
KR100500859B1 (ko) 2005-07-14
NZ333809A (en) 2000-07-28
CA2261564A1 (en) 1998-02-12
CN1176947C (zh) 2004-11-24
DK0915911T3 (da) 2004-03-08
BG103128A (bg) 2000-05-31
EP0915911A1 (en) 1999-05-19
LV12293B (en) 2000-11-20
JP2001500845A (ja) 2001-01-23
FI990126L (fi) 1999-03-31
FI990126A7 (fi) 1999-03-31
JP2009057386A (ja) 2009-03-19
PT915911E (pt) 2004-03-31
RU2203286C2 (ru) 2003-04-27
EE9900039A (et) 1999-08-16
LV12293A (lv) 1999-06-20
IS4962A (is) 1999-01-29
WO1998005683A1 (en) 1998-02-12
JP4224111B2 (ja) 2009-02-12
ES2207740T3 (es) 2004-06-01
EP0915911B1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
BR9711002B1 (pt) análogo do hormÈnio da paratireóide para o tratamento de osteoporose.
JP4620309B2 (ja) 骨粗鬆症治療用副甲状腺ホルモン類似体
US6541450B1 (en) Parathyroid hormone analogues for the treatment of osteoporosis
US5556940A (en) Parathyroid hormone analogues for the treatment of osteoporosis
US5955425A (en) Parathyroid hormone analogues for the treatment of osteoporosis
JP2003238595A (ja) 副甲状腺ホルモンの類似体
US20090226477A1 (en) Pth2 receptor selective compounds
JP3621099B2 (ja) 骨原性成長オリゴペプチドおよびそれを含む医薬組成物
EP1352912A1 (en) Parathyroid hormone analogues for the treatment of osteoporosis
HK1059939A (en) Parathyroid hormone analogues for the treatment of osteoporosis
CA2599885A1 (en) Parathyroid hormone analogues for the treatment of osteoporosis

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: PARA QUE A PETICAO NO 429/RS DE 20/02/2002 SEJA ACEITA, APRESENTE A PETICAO DE DESARQUIVAMENTO DO PEDIDO, BEM COMO A RETRIBUICAO RELATIVA AO CUMPRIMENTO DE EXIGENCIA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/09/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 16A, 17A E 18A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.